Introduction
Psychedelic phenylethanamines 2 have been known and studied for decades, generating much interest and enthusiasm in some quarters -and corresponding alarm in others. [3] [4] [5] [6] Though drawing less scrutiny than better known psychedelics like LSD or psilocybin, strictly speaking these are not novel materials. [7, 8] In contrast, N-benzyl phenylethanamines progressed from earliest published reports [9] [10] [11] [12] [13] [14] and subsequent research [15, 16] to ready grey-market availability and ultimately prohibition -in the UK [17, 18] and the USA [19] -in less than 20 years.
Here we report the 1 H NMR spectrum of 28 grey-market phenyl ethanamines and N-benzyl phenylethanamines. The spectra of ca. 30 grey-market tryptamines will be the subject of a later report.
The advent and rapid expansion of electronic commerce in grey-market research chemicals has been startling. [20] [21] [22] Hundreds of formerly obscure substances, once unobtainable to most in any practical sense are now within reach. [23] For some, legal and affordable reach as well. A wide-ranging review of the evolving new-drug landscape is provided by Brandt et al. [24] Nevertheless, an inherent weakness of grey markets is the absence of regulatory oversight. Fleeting, unreliable, or fraudulent vendors are not uncommon. The reputation of a well-regarded source may, gradually or abruptly, decline. The slide from principled vendor to scam artist is well worn. For the customer, authenticating grey-market products is essentialand a considerable challenge.
Few organizations exist to meet this need. EcstasyData.org, a leading drug-analysis service, has traditionally focused on testing single-dose formulations (e.g. a pill or capsule) held out as "ecstasy." More recently, they expanded their mandate to include research chemicals. 3 However, at $100 per analyte the cost seemed prohibitive for the summary level of analysis provided -a restriction imposed by the Drug Enforcement Administration (DEA). 4 Fortunately, the University of Toronto offers several forms of analysis for external clients including NMR and mass spectrometry (MS). We wondered if "walk-in" 1 H NMR analysis combined with contemporary spectral-analysis software might allow even inexperienced investigators to verify the composition of grey-market research chemicals with a reasonable degree of confidence. The attraction of 1 H NMR over MS is threefold: (1) the cost is significantly lower; less than 25 percent, (2) it provides sufficient information to potentially identify an unknown in the absence of a reference spectrum, [25] and (3) aryl regioisomers are more readily differentiated.
Simply, we wanted to know if the grey-market research chemicals being sold were in fact "as advertised." Would the spectrum be consistent with the substance as alleged? Was this powder labelled x, actually x, or not? In November 2012, after an engaging discussion with Timothy Burrow, Director of the University of Toronto NMR Facility, we began our investigation to confirm the identity of grey-market research chemicals.
Limitations and bias
Our objective was chiefly to check the identity of our unknowns, not unlike how presumptive spot-colour tests are used. [26] It was sufficient to assign a pass/fail grade to an unknown; spectra consistent with published results passed. 1 We have included every phenylethanamine spectrum acquired -nothing has been excluded. Our analytes were purchased over several years from 15 vendors across North America and Europe. Though we consider this to be a fair representation of the grey market during that time it is not without potential selection bias. While no official regulatory oversight exists for this market, anecdotal reports posted at SafeOrScam.com 2 provided some guidance. Patently disreputable vendors were excluded. Our analytes were not selected at random and our findings should be interpreted accordingly.
The "purity" values we report were provided by the verification module of the MestReNova software. Though we do not suggest these values necessarily reflect actual analyte purity, they are comparable in magnitude and implied precision (misleading or not) to vendor-supplied values. 1 H NMR spectra for analytes P0 and P17 were recorded on an Agilent DD2 NMR spectrometer operating at 699.8 MHz and equipped with an HFCN Cold Probe. All other analytes were recorded on an Agilent DD2 NMR spectrometer operating at 499.67 MHz and equipped with an XSens Cold Probe.
Approximately 5 mg of each analyte was placed in a capped glass vial, labelled, and submitted for analysis. Except where noted spectra were acquired in deuterated dimethyl sulfoxide (DMSO-d6) from single-use ampoules to minimize the presence of water. DMSO-d6 was chosen to dissolve analytes in free base or salt form along with any impurities which might be present. Dissolution was reportedly facile and complete in every case, leaving no residual insoluble material. Dissolved analytes were loaded without filtering into a 3 mm NMR sample tubes. Spectra acquired in DMSO-d6 were referenced to the solvent signal at δ = 2.50 ppm.
Results
Analyte structures and codes are shown in Figures 1-3 . Analyte codes, substitution patterns, and preferred IUPAC names (PIN) are listed in Table 1. 1 H NMR spectral data is summarized in Table 2 . Multiplets for moieties common to all scaffolds are grouped together in Table 3 . Multiplets for moieties common only to the N-benzyl and N-benzylidene PEA scaffolds are grouped together in Table 4 , ordered by shift. Multiplets for para-substituents, β-substituents, and atypical moieties are detailed in Table 5 . The per cent ratio of the total analyte integral over the total spectrum integral as reported by Mestrelab's MestReNova software except where noted. d br, broad; d, doublet; h, hextet; hept, heptet; obs, partially obscured; m, multiplet; q, quartet; s, singlet; t, triplet; vb, very broad; J, coupling constant; Ph, phenyl. e Purity as labelled by vendor. f Converted to the hydrochloride salt from the supplied free base oil following Shulgin and Shulgin, [3] recrystallized in oxolane (tetrahydrofuran). g A second spectrum acquired in DMF-d7 resolved a multiplet partially obscured in the original spectrum acquired in DMSO-d6. h Alleged and sold as 2C-C, a claim unsupported by the spectrum which strongly suggests 2C-E. i Formulated as the free base. 
Analysis
Almost all of the analytes appear to be formulated as simple aminium salts e.g. a hydrochloride, facilitating comparison. The protonated aminium resonance typically appears as a broad singlet, near or downfield of 8 ppm in primary amines; 9.15 ppm in secondary amines. The unprotonated amine group found in the two free base analytes resonates as a very broad singlet upfield of 2 ppm (cf. P1: 2C-H · HCl vs. 2C-H in Figure 4) . The quintet at 2.50 ppm is characteristic of trace amounts of the partially deuterated solvent DMSO-d5.
The phenyl ring substitution patterns most often encountered are the 2,5-and 3,5-dimethoxy with para-substitution. Though purported TMA-6 1 has occasionally been seen, the 2,6-dimethoxy pattern appears largely absent from the grey market.
1 TMA-6: 1-(2,4,6-trimethoxyphenyl)propan-2-amine. A 4-substituted 2,5-dimethoxy spectrum typically exhibits a discrete 3H singlet for each methoxy substituent and a discrete 1H singlet for each unsubstituted aryl hydrogen. The methoxy groups are not magnetically equivalent, nor are the aryl hydrogens, and each may resonate at a discrete shift. In some cases, these singlet resonances may overlap or appear isochronous, which has particularly been reported in the earlier literature.
In a 4-substituted 3,5-or 2,6-dimethoxy spectrum, both methoxy substituents are magnetically equivalent by symmetry, as are both aryl hydrogens. The methoxy groups appear as a single 6H singlet, the aryl hydrogen as a 2H singlet. Figure 4 shows predicted spectra for 2-(4-deuterophenyl)ethan-1-amine with 2,5-, 3,5-, and 2,6-dimethoxy substitution. The 4-deutero substituent functions as a placeholder keeping the simulation free of spurious peaks arising from ortho-and metacoupling of the aryl hydrogen. H NMR spectra have been reported for 2C-H in DMSO-d6, [29] in CDCl3, [15, 30] and in D2O; [31] [32] [33] and for the NBOMe analogue 25H-NBOMe 1 in DMSO-d6 [29] Shaler and Padden have compared 1 H NMR spectra of the base and the hydrobromide salt of the α-methylated homologue 2 in CDCl3.
[34] 1 H NMR spectra have been reported for the N,α-dimethyl homologues (i.e. the methamphetamine analogues) of 13 mono-, di-, and trimethoxyphenylethanamines in CDCl3. [35] The 4-X family: 4-halo-2,5-dimethoxyphenyl pattern Members of the 4-X family share a 4-halo-2,5-dimethoxyphenyl substitution pattern, with a bromo, chloro or iodo parasubstituent. Shulgin reported the 4-fluoro analogue 3 largely inactive even at 250 mg, an order of magnitude less potent than of the other three. [3] Alleged 2C-F has been advertised on the grey market lately. None has been obtained and its actual composition is unknown.
Regulatory hurdles precluded obtaining the controlled 4-bromo analogue, 2C-B. [36] However, the 2C-B ring substitution pattern is present in other, more recent arrivals to the grey market. Samples alleged to be 25B-NBOMe and bk-2C-B, uncontrolled analogues of 2C-B, were purchased instead.
The 4-X spectra in Figures 5 and 6 show a clear correlation between the 4-halo substituent and the shift of the two phenyl hydrogen. Table 6 compares our findings (shaded rows) with reported data acquired in DMSO-d6. The consistency of the shift separation (Δδ) suggests a facile method for differentiating the 4-halo substituent of 4-X family compounds. P17: bk-2C-B is the only β-oxo 1 phenylethanamine we have seen and our only analyte of this kind. In contrast, a plethora of grey-market β-oxo-phenylpropamines and higher homologues ("cathinones") are on offer, typically as secondary or cyclic amines.
The effects of the β-oxo group is readily seen in Figure 5 . The highly conserved pair of 2H α-and β-multiplets seen in the other three spectra are replaced by a 2H pseudo-quartet from the α methylene protons, while the 3H aminium peak shows a trace of triplet symmetry. This suggests possible coupling, as reported in an unattributed analysis of 1 H, 13 C, and 2-D spectra. [39] A similar pseudo-quartet appears in the supplementary data of the analysis by Power et al. [38] The aryl methoxy peaks are shifted noticeably downfield and the aryl hydrogen peaks even more so though their separation is not appreciably effected (see Table 6 ). 1 H NMR spectra of two additional analogues of 25I-NBOMe are shown in Figure 6 . The NBOMe moiety is replaced by a 2-hydroxybenzyl group (NBOH) in analyte B4: 25I-NBOH, and by 2H-(1,3-benzodioxol-4-yl)methyl group (NBMD) in analyte B5: 25I-NBMD. 2 Comparing the B3: 25I-NBOMe and B4: 25I-NBOH spectra, in the latter only two 3H singlet methoxy peaks are present, reflecting the loss of the benzyl methoxy group; the characteristic multiplet pattern of the four benzyl protons is shifted upfield about 0.13 ppm on average; and in place of a broad 2H aminium peak at 9.15 ppm we found a very broad 3H peak spanning ca. 2 ppm at 9.22 ppm (not discernable in Figure  6 ; see Table 3 ). This signal may result from intramolecular hydrogen bonding and proton exchange between the phenolic ortho-hydroxyl group of the NBOH moiety and the protonated amine, perhaps facilitated by the hydrogen-bond accepting solvent. However, both Heim [15] and Hansen [16, 37] report a discrete and sharp phenolic peak in DMSO-d6.
The spectrum of analyte B5: 25I-NBMD is markedly different from its NBOMe and NBOH analogues. It appears to be the only N-benzyl analyte formulated as the free amine rather than an aminium salt, consistent with the presence of a 1H upfield peak 2 NBMD stems from N-BenzylMethyleneDioxy. IUPAC has ruled methylenedioxy unacceptably ambiguous (is it -OCH2O-or -CH2OO-?) and deprecated. at 1.98 ppm, the absence of any 2H downfield peak, and the substantial upfield shift of the entire spectrum (cf. P1 as the free base vs. the hydrochloride salt in Figure 4) . Also, the α-and β-methylene groups have coalesced into a 4H multiplet, the familiar splitting pattern of the NBOMe/NBOH benzyl protons is absent, and a 2H singlet from the benzodioxole methylene group is seen at 5.96 ppm.
1
H NMR spectra have been reported for 2C-B in DMSO-d6, [29] in CDCl3, [15, 40] in CD3OD, [41] [42] [43] and in D2O [31, 32, 42, 44] ; for 2C-C in CDCl3 [45, 46] and in D2O [31, 46] ; for 2C-I in CDCl3 [43] and in D2O [31, 32, 47, 48] ; for bk-2C-B in DMSO-d6 [38, 39] and in CDCl3. [49] 1 H NMR spectra have been reported for 25B-NBOMe in DMSO-d6 [16, 37] and in CDCl3 [15, 50] ; for 25C-NBOMe in DMSO-d6, [37] in CDCl3, [51] and in CD3OD [16, 52] ; for 25I-NBOMe in DMSO-d6, [16, 37, 53] in CDCl3, [15, [54] [55] [56] and in CD3OD [57] ; for 25I-NBOH in DMSO-d6 [15, 16, 37] ; for 25I-NBMD in DMSO-d6. [16, 37] The 4-R family: 4-alkyl-2,5-dimethoxyphenyl pattern
Five primary amine analytes ( Figure 7 ) and four secondary amine analytes (Figure 8 ) share the 4-alkyl-2,5-dimethoxyphenyl pattern where the 4-alkyl substituent is methyl (P2: 2C-D, P16: BOD, B6: 25D-NBOMe), ethyl (P3: 2C-E, B7: 25E-NBOMe), propyl (P4: 2C-P), or isopropyl (P5: 2C-IP, B8: 25IP-NBOMe). Analyte B9: 25G-NBOMe is the 3,4-dimethyl homologue of B6. Fortunately, the 4-alkyl substitution introduces additional peaks while leaving the core (P1: 2C-H) spectrum essentially undisturbed, simplifying analysis.
In analyte P2: 2C-D the line broadening of the 4-methyl peak (apparent 3H singlet at 2.13 ppm arises from long range coupling to the ortho-hydrogen at ring position 3, which shows similar line broadening. Analogous coupling is seen in the β-methoxy analogue P16: BOD, and the NBOMe analogue B6: NBOMe. The coupling constants are consistent with the published value of 0.7 Hz.
[58] Figure 7 : 1 H NMR spectra of 4-R family analytes P2: 2C-D; P16: BOD; P3: 2C-E; P4: 2C-P; P4: 2C-P in DMF-d7; P5: 2C-IP.
In the P3: 2C-E spectrum, the classical ethyl group splitting pattern is seen: a 2H quartet and 3H triplet. Similarly, the isopropyl group of P5: 2C-IP is readily identified by the characteristic methine proton 1H heptet signal and the 6H doublet signal from the adjacent, isochronous methyl groups.
The DMSO-d6 solvent signal at 2.50 ppm hinders interpretation of the P4: 2C-P spectrum by obscuring the expected 2H triplet of the propyl group while the corresponding 2H multiplet and 3H triplet are clearly present. A second spectrum, acquired in deuterated N,N-dimethylformamide (DMF-d7), allows for an unobstructed view of the propyl multiplet.
Interestingly, though the 3H triplet of the terminal methyl moiety appears typical, much like the corresponding peak seen in P3: 2C-E, the splitting pattern of the methylene protons is more complex. The methylene group alpha to the ring does not split as a simple first-order triplet, nor does the methylene group beta to the ring split as a first-order hextet. The same divergence from simple first-order splitting is seen in the other propyl-substituted analytes.
1 H NMR spectra have been reported for 2C-D in CDCl3; for the regioisomer iso-2C-D 1 in CDCl3 and in CD3OD [59] ; for 2C-E in DMSO-d6 [60] and in D2O [61] ; for 2C-P in D2O [48] ; for BOD in CDCl3 [62] and in D2O. [63] We have not found 1 H NMR spectra reported for 2C-IP or 25IP-NBOMe. 1 iso-2C-D: 2-(2,4-dimethoxy-3-methylphenyl)ethan-1-amine. 1 H NMR spectra have been reported for 25D-NBOMe in DMSO-d6 [16, 37, 64] ; for 25E-NBOMe in DMSO-d6 [16, 37, 64] and in CDCl3 [65] ; for 25G-NBOMe in DMSO-d6. [64] Figure 8: 1 H NMR spectra of B6: 25D-NBOMe; B7: 25E-NBOMe; B8: 25IP-NBOMe; B9: 25G-NBOMe.
The 4-RS family: 4-alkylsulfanyl-2,5-dimethoxyphenyl pattern
The 4-RS family analytes ( Figure 9 ) are sulfide 1 analogues of 4-R family compounds, the result of interposing a sulfur atom between the phenyl ring and 4-alkyl substituent. Four of the analytes are members of this family, each a primary amine, where the alkyl substituent is methylsulfanyl (P8: 2C-T), ethylsulfanyl (P9: 2C-T-2) isopropylsulfanyl (P10: 2C-T-4), or propylsulfanyl (P11: 2C-T-7).
The splitting pattern arising from a particular alkyl substituent is the same in either family, e.g. 4-ethyl and 4-ethylsulfanyl. However, the alkyl-peak shifts of the 4-RS compounds are further downfield.
We have not seen the corresponding ether analogous on the grey market, the 4-alkoxy-2,5-dimethoxyphenylethanamine series. They have received scant mention in the literatureShulgin includes only one in PiHKAL, [3] an unenthusiastic account of 2C-O-4. 2 Cheng and Castagnoli report shifts between 3.97 and 3.78 ppm for the three methoxy substituents of 2C-O, 3 the 4-oxy analogue of 2C-T, a substantial and indicative downfield shift. [66] 1 Formerly thioether. H NMR spectra have been reported for 2C-T-2 in CDCl3, [67] in CD3OD, [43] and in D2O [48, 68] ; for 2C-T-4 in CDCl3, [69] and in D2O [48] ; for 2C-T-7 in CDCl3, [69] in CD3OD, [43] and in D2O. [48, 70] We have not found 1 H NMR spectra reported for 2C-T. The 1 H NMR spectrum has been reported for the α-methyl homologue 4 of 2C-T in D2O, [48] and for the α-methyl, α-ethyl, and N-methyl homologues of the 2C-T series (and the Ψ-2C-T series 5 ) in D2O. [71] Trachsel has synthesized additional members of the 2C-T series and has reported their spectra in D2O. [72] 4 ALEPH or DOT: 1-[2,5-dimethoxy-4-(methylsulfanyl)phenyl]propan-2-amine. 5 Alexander T. Shulgin introduced the prefix Ψ (Psi) as a notation for the 2,4,6-regioisomer of the corresponding 2,4,5-substituted compound. 
The 4-RO family: 4-alk[en]yloxy-3,5-dimethoxyphenyl pattern
Turning from the 2,5-to the 3,5-dimethoxy substitution pattern, the 4-RO family compounds are analogues of the natural product mescaline, 1 sometimes called "scalines." [73] Being a controlled substance in Canada, we were unable to include mescaline among our analytes. However, the NBOMe analogue of mescaline is not controlled and was obtained instead.
Six of the analytes belong to the 4-RO family, having a parasubstituent of methoxy (B10: M-NBOMe), ethoxy (P12: Escaline), propoxy (P13a, P13b: Proscaline), allyloxy (P14: AL), and methallyloxy (P15: MAL). 2 While allyloxy remains acceptable in general, prop-2-en-1-yloxy is the PIN. However, methallyloxy and methylallyloxy are deprecated; (2-methylprop-2-en-1-yl)oxy is the PIN. We've opted for brevity over dogma in this case.
As noted previously, the symmetrical ring substitution of the 4-RO compounds is evident from the 6H methoxy and 2H aryl proton peaks ca. 3.75 and 6.56 ppm, respectively. Here, as with the 4-R family, para-substitution leaves the spectrum otherwise undisturbed.
1 H NMR spectra have been reported for mescaline in DMSO-d6 [29, 74] and in CDCl3 [75] [76] [77] ; for proscaline in DMSO-d6. [53] We have not found 1 H NMR spectra reported for M-NBOMe, escaline, AL, or MAL. 1 H NMR spectra have been reported for the α-methyl homologues of proscaline, 3 AL, 4 and MAL 5 in D2O.
[78] 1 H NMR spectra have been reported for TMA, 6 the α- two regioisomers of interest, in CD3OD. [79] Recently, a regioisomer of mescaline, isomescaline, 3 was prepared and the 1 H NMR spectrum in DMSO-d6 reported by Martins. [30] Reportedly without activity, it seems an unlikely candidate for the grey market. [3] The NBOMe and NBOH splitting pattern
The N-benzyl protons of the NBOMe and NBOH analytes resonate with a distinctive splitting pattern and at highly consistent shifts of 7.5-7.0 ppm (see Table 4 ). The NBOMe splitting pattern is consistent with a largely first-order ABCD spin system having six coupling constants: three ortho ( . The aryl region of the B1: 25B-NBOMe spectrum and the first-order J-tree analysis is shown in Figure 11 .
Each of the outer two protons (3' and 6′) is ortho-and metacoupled to the inner protons (4′ and 5') and appears as a doublet of doublets (dd). The two inner protons are also orthocoupled to each other, producing a further split into a doublet 1 TMA-2: 1-(2,4,5-trimethoxyphenyl)propan-2-amine. 2 TMA-6: 1-(2,4,6-trimethoxyphenyl)propan-2-amine. 3 Isomescaline or IM: 2-(2,3,4-trimethoxyphenyl)ethan-1-amine.
of doublet of doublets (ddd). Because the ortho-coupling constants are quite close -less than 1 Hz apart -a ddd coupling may appear as a triplet of doublets (td). There is no apparent para-coupling between the outer protons.
Interestingly, both the shifts and the ordering of the benzyl peaks may depend on the solvent. Published NBOMe spectra acquired in DMSO-d6 align quite closely with our own and retain the 6′, 4′, 3′, 5′ multiplet sequence. [37 supp. data] In contrast, for a spectrum of 25C-NBOMe acquired in CDCl3 the overall splitting pattern is preserved but the ordering is not, becoming 6′, 4′, 5′, 3′. [51] Multiplets 3′ and 5′ have traded places. A ubiquitous, unanticipated peak at 8.15 ppm A characteristic peak was noted in the spectrum for 9 of the 10 N-benzyl analytes ( Figure 12 ). We initially suspected the sharp singlet at 8.15 ppm was the signal from residual amounts of the benzaldehyde precursors. However, literature shifts were notable more downfield than anticipated, appearing around 10.2-10.3 ppm. [80, 81] Following the synthetic route outlined by Casale and Hays (Scheme 1), we wondered if the peak could be coming from traces of the unreduced imine intermediate of the reductive amination of the parent phenethylamine with the respective benzaldehyde. [82] Kappe et al. reported a singlet at 8.15 ppm in the spectrum of the unsubstituted imine (E)-1-phenyl-N-(2-phenylethyl)methanimine (1), which seemed promising. [83] To test this hypothesis we acquired the 1 H NMR spectra of two commercially available N-benzylidene phenylethanamines: IM1: 25H-NBOMe imine (2) and IM2: 25I-NBOMe imine (3).
The spectra of the reference did not conclusively match the observed impurities for the respective compounds. The imine analog of 25H-NBOMe, IM1, gave a singlet at 8.56 ppm; IM2, the imine analog of 25I-NBOMe, a singlet at 8.54 ppm. The distinct shifts from the observed 8.13-8.15 ppm shift made the imine an unlikely candidate. Potentials precursors 2-methoxybenzaldehyde, 1,3-benzodioxole-4-carbaldehyde, the unsubstituted primary phenylethanamines, and residual solvents were each investigated but proved unsupported by Figure 12 : A ubiquitous, unanticipated peak at 8.15 ppm observed in the 1 H NMR spectra of NBOMe and NBOH analytes.
Scheme 1: Synthetic route to N-benzyl phenylethanamines via the N-benzylidene, following Casale and Hays. [82] experimental, predicted, or literature 1 H NMR shift values. Though this peak might indeed be an artifact of Scheme 1 we did not pursue this line any further.
The spectrum of B5: 25I-NBMD is unique among the N-benzyl analytes in having no peak at 8.15 ppm. We believe B5 is also the only free base N-benzyl analyte, having a broad upfield amine peak and no downfield aminium peak. Our analytes include primary, secondary, and tertiary amines; the peak at 8.15 ppm is present only in the spectra of protonated secondary amines.
In each case the peak's shift is precisely 8.15 ppm, while the shift the aminium peaks differ by as much as 0.18 ppm. This seems to rule out the peaks being somehow coupled. No correlation was found between the area of the two peaks, further evidence against coupling.
Approaching the problem from another angle we searched the literature for peaks of shift 8.15 ppm. Robertson et al. [84] report conditions where the formyl proton of dimethylformamide (DMF) resonates as a sharp singlet at 8.15 ppm in DMSO-d6.
Though reporting a shift of ca. 7.95 ppm in free DMF, they found the formyl proton signal moves downfield to 8.15 ppm when the amine lone pair forms a hydrogen bond and the quaternary amine orbitals undergo sp 3 hybridization. With the loss of the nitrogen π-orbital, the delocalized bonding found in free DMF is lost (see Figure 15) , rotation about the C-N bond is no longer inhibited, and the amine methyl groups become equivalent, resonating as a 6H singlet at 2.54 ppm.
Though the majority of the spectra stacked in Figure 12 indeed include a peak at 2.54 ppm, the protonated DMF theory would seem to demand the area of the upfield dimethyl peak be six times the area of the downfield formyl peak. Tantalizing but far from conclusive. A more satisfactory explanation must await further investigation. We have not found 1 H NMR spectra reported for 25H-NBOMe imine or 25I-NBOMe imine. Spectra in CDCl3 are available from the vendor, Cayman Chemical.
Conclusion
We found only one clear case of significant misrepresentation among our analytes. Analyte P6a was sold and labelled as 2C-C, a claim unsupported by the 1 H NMR spectrum which suggests 2C-E. In addition, the spectrum of P6a aligns closely with that of P3: 2C-E, purchased from the same vendor around the same time. It seems likely analyte P6a was mislabelled by the vendor.
Fortunately, because 2C-C and 2C-E are active at comparable levels [3] this did not constitute a public health emergency as happened in 2009, for example, when the extremely potent and long-acting compound bromo-dragonFLY 1 was sold as 2C-B-FLY, 2 an order of magnitude less active. [21, 85] Furthermore, the vendor of the mislabelled 2C-E closed several years ago.
On reflection -and the future of open, "legitimate" research "Experience is essential and to become really proficient in this area, you need to critically examine literally thousands of spectra." [86] When we began this investigation our knowledge of NMR was limited, as was our experience interpreting spectra. The sophisticated and highly regarded Mestrelab software may, in retrospect, have inspired unrealistic expectations that interpreting spectra would be simple, even intuitive. Remarkably, as our investigation progressed so too did our intuition. As a non-traditional, self-directed approach to the study of NMR we found it highly effective. As a potential technique for harm reduction we concede "walk-in" 1 H NMR analysis is unlikely to supplant spot-colour testing any time soon.
The legal status of phenylethanamines in Canada has long been clear. [36] A terse notice released 1 August 2015 may muddy the water. Health Canada proposes to add "2C-phenethylamines and their salts, derivatives, and isomers, and the salts of their derivatives and isomers" to Schedule III of the Controlled Drugs and Substances Act (CDSA). [87, 88] What that means is far from clear -no elaboration is provided and the CDSA is equally unhelpful, absent any definition for 2C-phenethylamine, salt, derivative, or isomer. The legal status of a substance may be contested when made woolly, even if by design -what fresh grey area is this? Unfortunately, the inevitable consequences of further barriers to open, legitimate research are well documented. [89] [90] [91] [92] [93] [94] [95] We are hugely indebted to Timothy Burrow, Darcy Burns, and Dmitry Pichugin of the University of Toronto NMR facility for their generous assistance and encouragement. Simon Brandt's thoughtful insight and unflagging direction has been invaluable. Elias Vervecken's many candid and bracing observations were gratefully received. Peter Ng reviewed the tabular and supplementary data for consistency and offered helpful suggestions. S.J.C. thanks Lee Fadness for his tacit support and generous accommodation, over many years.
We acknowledge the exemplary support and assistance provided by Jedi Masters Carlos Cobas, Santiago Domínguez, Cristina Geada, Olalla Lema, and Pablo Monje of Mestrelab Research, and the donation of an academic licence. Cayman Chemical provided 1 H NMR CDCl3 spectra of their N-benzylidene products. All procurement and analysis was done in Canada under the auspices of Isomer Design, Toronto.
Finally and with deep regret we mark the loss of distinguished psychedelic researcher and author Alexander "Sasha" Shulgin.
